Catalyst Wire Dossier Catalyst Wire Dossier

Microlyvaq™

· Biogenea Pharmaceuticals Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Microlyvaq™, covering 2025-12-16 to 2025-12-16. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of the Therapeutic Effectiveness of In-silico-Designed, Machine Learning Inspired, and Quantum-molecularly Coupled Personalized Neoantigenic Vaccines Microlyvaq™ in Patients With Advanced Non-small Cell Lung Cancer [EARLY_Phase 1]

See pricing